Embera NeuroTherapeutics, Inc.

Embera is a specialty pharma company developing a novel treatment for the $1.9B smoking cessation market and cocaine dependence (no approved treatments today).

  • Stage Product In Development
  • Industry Biotechnology
  • Location Sudbury, MA, USA
  • Currency USD
  • Founded January 2007
  • Employees 1
  • Website emberaneuro.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free